Download PDF
CC BY-NC-ND 4.0 · Laryngorhinootologie 2022; 101(S 01): S79-S89
DOI: 10.1055/a-1671-1825
Referat

Innovative Technologien für optimiertes künstliches Sehen

Article in several languages: deutsch | English
Peter Walter
› Further Information
Also available at
   Permissions and Reprints

Zusammenfassung

Trotz deutlicher Fortschritte in der Therapie schwerer Augenerkrankungen können bestimmte Formen der Erblindung bis heute nicht geheilt oder gebessert werden. Dazu gehört beispielsweise die Retinitis pigmentosa, eine erbliche Degeneration der Photorezeptoren. Technologieansätze mit implantierbaren Sehprothesen, deren Prinzip in einer elektrischen Stimulation verbleibender Nervenzellen in der Retina oder im Cortex, wurden bereits bei einer Reihe von Patienten mit begrenzten Ergebnissen erprobt. Neue Befunde in der Biologie der Erkrankungen aber auch neue technologische Entwicklungen machen hier Hoffnung auf bessere Ergebnisse in der Zukunft.

Schlüsselwörter

Künstliches Sehen - Erblindung - Retina Implantate - Corteximplantate - Retinadystrophie - Makuladegeneration

Key words

Artificial Vision - Blindness - Retinal Implants - Cortical Implants - retinal dystrophy - macular degeneration


Publication History

Article published online:
23 May 2022

© 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Aghaizu N, Kruczek K, Gonzalez-Cordero A, Ali R, Pearson R, Dunnett S, Bjorklund A. 2017; 231: 191-223 DOI: 10.1016/bs.pbr.2017.01.001.
    CrossrefPubMed
  • 2 Aisenbrey S, Bartz-Schmidt KU, Walter P, Hilgers RD, Ayertey H, Szurman P, Thumann G. 2007; 125: 1367-1372 DOI: 10.1001/archopht.125.10.1367.
    CrossrefPubMed
  • 3 Aisenbrey S, Lafaut BA, Szurman P, Hilgers RD, Esser P, Walter P, Thumann G. 2006; 124: 183-188 DOI: 10.1001/archopht.124.2.183.
    CrossrefPubMed
  • 4 Al-Atabany W, Degenaar P. 2011; 432-435
    PubMed
  • 5 Al-Atabany W, McGovern B, Mehran K, Berlinguer-Palmini R, Degenaar P. 2013; 60: 781-791 DOI: 10.1109/TBME.2011.2177498.
    CrossrefPubMed
  • 6 ALGVERE P, BERGLIN L, GOURAS P, SHENG Y. 1994; 232: 707-716 DOI: 10.1007/BF00184273.
    CrossrefPubMed
  • 7 Ayton L, Barnes N, Dagnelie G, Fujikado T, Goetz G, Hornig R, Petoe M. 2020; 131: 1383-1398 DOI: 10.1016/j.clinph.2019.11.029.
    CrossrefPubMed
  • 8 Ayton L, Blamey P, Guymer R, Luu C, Nayagam D, Sinclair N, Res BVA. 2014 9. 10.1371/journal.pone.0115239
    PubMed
  • 9 Barrett J, Berlinguer-Palmini R, Degenaar P. Optogenetic approaches to retinal prosthesis. Visual Neuroscience 2014; 31: 345-354 DOI: 10.1017/S0952523814000212.
    CrossrefPubMedGoogle Scholar
  • 10 Barriga-Rivera A, Suaning G. Visual prostheses, optogenetics, stem cell and gene therapies: splitting the cake. Neural Regeneration Research 2018; 13: 805-806 10.4103/1673-5374.232469
    CrossrefPubMedGoogle Scholar
  • 11 Biswas S, Haselier C, Mataruga A, Thumann G, Walter P, Muller F. Pharmacological Analysis of Intrinsic Neuronal Oscillations in rd10 Retina. Plos One. 2014 9. 10.1371/journal.pone.0099075
    PubMedGoogle Scholar
  • 12 Busskamp V, Roska B. Optogenetic approaches to restoring visual function in retinitis pigmentosa. Current Opinion in Neurobiology 2011; 21: 942-946 DOI: 10.1016/j.conb.2011.06.001.
    CrossrefPubMedGoogle Scholar
  • 13 Cideciyan A, Jacobson S. Leber Congenital Amaurosis (LCA): Potential for Improvement of Vision. Investigative Ophthalmology & Visual Science 2019; 60: 1680-1695 10.1167/iovs.19-26672
    CrossrefPubMedGoogle Scholar
  • 14 da Cruz L, Dorn J, Humayun M, Dagnelie G, Handa J, Barale P, Grp AIS. Five-Year Safety and Performance Results from the Argus II Retinal Prosthesis System Clinical Trial. Ophthalmology 2016; 123: 2248-2254 DOI: 10.1016/j.ophtha.2016.06.049.
    CrossrefPubMedGoogle Scholar
  • 15 Diakatou M, Manes G, Bocquet B, Meunier I, Kalatzis V. Genome Editing as a Treatment for the Most Prevalent Causative Genes of Autosomal Dominant Retinitis Pigmentosa. International Journal of Molecular Sciences. 2019 20. 10.3390/ijms20102542
    PubMedGoogle Scholar
  • 16 Dong N, Sun X, Degenaar P, Kollias N, Choi B, Zeng H, Mandelis A. IMPLANTABLE OPTRODE DESIGN FOR OPTOGENETIC VISUAL CORTICAL PROSTHESIS. Photonic Therapeutics and Diagnostics Viii, Pts 1 and 2 2012; 82076a 10.1117/12.912386
    PubMedGoogle Scholar
  • 17 Duret F, Brelen M, Lambert V, Gerard B, Delbeke J, Veraart C. Object localization, discrimination, and grasping with the optic nerve visual prosthesis. Restorative Neurology and Neuroscience 2006; 24: 31-40
    PubMedGoogle Scholar
  • 18 Erbsloh A, Viga R, Walter P, Kokozinski R, Grabmaier A, Soc IC. Implementation of a Charge-Controlled Stimulation Method in a Monolithic Integrated CMOS-Chip for Excitation of Retinal Neuron Cells. 2017
    PubMedGoogle Scholar
  • 19 Fujikado T, Kamei M, Kishima H, Morimoto T, Kanda H, Sakaguchi H, Ozawa M. One-Year Outcomes of 49-Channel Suprachoroidal-Transretinal Stimulation (STS) Retinal Prosthesis in Patients with Advanced Retinitis Pigmentosa. Investigative Ophthalmology & Visual Science. 2016 57.
    PubMedGoogle Scholar
  • 20 Garg S, Federman J. Optogenetics, visual prosthesis and electrostimulation for retinal dystrophies. Current Opinion in Ophthalmology 2013; 24: 407-414 DOI: 10.1097/ICU.0b013e328363829b.
    CrossrefPubMedGoogle Scholar
  • 21 Gekeler K, Bartz-Schmidt K, Sachs H, MacLaren R, Stingl K, Zrenner E, Gekeler F. Implantation, removal and replacement of subretinal electronic implants for restoration of vision in patients with retinitis pigmentosa. Current Opinion in Ophthalmology 2018; 29: 239-247 DOI: 10.1097/ICU.0000000000000467.
    CrossrefPubMedGoogle Scholar
  • 22 Haselier C, Biswas S, Rosch S, Thumann G, Muller F, Walter P. Correlations between specific patterns of spontaneous activity and stimulation efficiency in degenerated retina. Plos One. 2017 12. 10.1371/journal.pone.0190048
    PubMedGoogle Scholar
  • 23 Lee V, Nau A, Laymon C, Chan K, Rosario B, Fisher C. Successful tactile based visual sensory substitution use functions independently of visual pathway integrity. Frontiers in Human Neuroscience 2014; 8 10.3389/fnhum.2014.00291
    PubMedGoogle Scholar
  • 24 Lohmann TK, Haiss F, Schaffrath K, Schnitzler AC, Waschkowski F, Barz C, Walter P. The very large electrode array for retinal stimulation (VLARS)?A concept study. Journal of Neural Engineering. 2019 16. 10.1088/1741-2552/ab4113
    PubMedGoogle Scholar
  • 25 Menzel-Severing J, Laube T, Brockmann C, Bornfeld N, Mokwa W, Mazinani B, Roessler G. Implantation and explantation of an active epiretinal visual prosthesis: 2-year follow-up data from the EPIRET3 prospective clinical trial. Eye 2012; 26: 502-509 DOI: 10.1038/eye.2012.35.
    CrossrefPubMedGoogle Scholar
  • 26 Moisseiev E, Mannis M. Evaluation of a Portable Artificial Vision Device Among Patients With Low Vision. Jama Ophthalmology 2016; 134: 748-752 DOI: 10.1001/jamaophthalmol.2016.1000.
    CrossrefPubMedGoogle Scholar
  • 27 Mokwa W, Goertz A, Koch C, Krisch I, Trieu HK, Walter P. Ieee Intraocular Epiretinal Prosthesis to Restore Vision in Blind Humans. In 2008 30th Annual International Conference of the Ieee Engineering in Medicine and Biology Society 2008; Vols 1-8 pp 5790- +) 
    PubMedGoogle Scholar
  • 28 Montes VR, Gehlen J, Luck S, Mokwa W, Muller F, Walter P, Offenhausser A. Toward a Bidirectional Communication Between Retinal Cells and a Prosthetic Device – A Proof of Concept. Frontiers in Neuroscience 2019; 13: 19 10.3389/fnins.2019.00367
    CrossrefPubMedGoogle Scholar
  • 29 Nishida K, Sakaguchi H, Kamei M, Cecilia-Gonzalez C, Terasawa Y, Velez-Montoya R, Quiroz-Mercado H. Visual Sensation by Electrical Stimulation Using a New Direct Optic Nerve Electrode Device. Brain Stimulation 2015; 8: 678-681 DOI: 10.1016/j.brs.2015.03.001.
    CrossrefPubMedGoogle Scholar
  • 30 Rizzo J, Wyatt J, Loewenstein J, Kelly S, Shire D. Perceptual efficacy of electrical stimulation of human retina with a microelectrode array during short-term surgical trials. Investigative Ophthalmology & Visual Science 2003; 44: 5362-5369 10.1167/iovs.02-0817
    CrossrefPubMedGoogle Scholar
  • 31 Rizzo S, Barale PO, Ayello-Scheer S, Devenyi RG, Delyfer MN, Korobelnik JF, Humayun MS. ADVERSE EVENTS OF THE ARGUS II RETINAL PROSTHESIS Incidence, Causes, and Best Practices for Managing and Preventing Conjunctival Erosion. Retina-the Journal of Retinal and Vitreous Diseases 2020; 40: 303-311 10.1097/iae.0000000000002394
    PubMedGoogle Scholar
  • 32 Roessler G, Laube T, Brockmann C, Kirschkamp T, Mazinani B, Goertz M, Walter P. Implantation and Explantation of a Wireless Epiretinal Retina Implant Device: Observations during the EPIRET3 Prospective Clinical Trial. Investigative Ophthalmology & Visual Science 2009; 50: 3003-3008 10.1167/iovs.08-2752
    CrossrefPubMedGoogle Scholar
  • 33 Rosenfeld J. The Development of a Wireless Multi-electrode Cortical Prosthesis for Restoration of Vision in Blind Individuals. Journal of Neurosurgery 2015; 123: A486-A486
    PubMedGoogle Scholar
  • 34 Russell S, Bennett J, Wellman J, Chung D, Yu Z, Tillman A, Maguire A. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial. Lancet 2017; 390: 849-860 DOI: 10.1016/S0140-6736(17)31868-8.
    CrossrefPubMedGoogle Scholar
  • 35 Schaffrath K, Schellhase H, Walter P, Augustin A, Chizzolini M, Kirchhof B, Rizzo S. One-Year Safety and Performance Assessment of the Argus II Retinal Prosthesis: A Postapproval Study. Jama Ophthalmology 2019; 137: 896-902 DOI: 10.1001/jamaophthalmol.2019.1476.
    CrossrefPubMedGoogle Scholar
  • 36 Shivdasani M, Sinclair N, Dimitrov P, Varsamidis M, Ayton L, Luu C, Consortium BVA. Factors Affecting Perceptual Thresholds in a Suprachoroidal Retinal Prosthesis. Investigative Ophthalmology & Visual Science 2014; 55: 6467-6481 DOI: 10.1167/iovs.14-14396.
    CrossrefPubMedGoogle Scholar
  • 37 Stingl K, Bartz-Schmidt K, Besch D, Chee C, Cottriall C, Gekeler F, Zrenner E. Subretinal Visual Implant Alpha IMS – Clinical trial interim report. Vision Research 2015; 111: 149-160 DOI: 10.1016/j.visres.2015.03.001.
    CrossrefPubMedGoogle Scholar
  • 38 Stingl K, Schippert R, Bartz-Schmidt KU, Besch D, Cottriall CL, Edwards TL, Zrenner E. Interim Results of a Multicenter Trial with the New Electronic Subretinal Implant Alpha AMS in 15 Patients Blind from Inherited Retinal Degenerations. Frontiers in Neuroscience. 2017 11. 10.3389/fnins.2017.00445
    PubMedGoogle Scholar
  • 39 Thumann G, Aisenbrey S, Schraermeyer U, Lafaut B, Esser P, Walter P, Bartz-Schmidt KU. Transplantation of autologous iris pigment epithelium after removal of choroidal neovascular membranes. Archives of Ophthalmology 2000; 118: 1350-1355
    CrossrefPubMedGoogle Scholar
  • 40 Tibbetts M, Samuel M, Chang T, Ho A. Stem cell therapy for retinal disease. Current Opinion in Ophthalmology 2012; 23: 226-234 DOI: 10.1097/ICU.0b013e328352407d.
    CrossrefPubMedGoogle Scholar
  • 41 Trieu HK, Goertz M, Koch C, Mokwa W, Walter P. Implants for Epiretinal Stimulation of Retinitis Pigmentosa Patients. In: O. Dossel & W. C. Schlegel (Eds.), World Congress on Medical Physics and Biomedical Engineering, Vol 25, Pt 11: Biomedical Engineering for Audiology, Ophthalmology, Emergency and Dental Medicine 2009; Vol. 25 pp. 80-+
    PubMedGoogle Scholar
  • 42 Veraart C, Duret F, Brelen M, Delbeke J. ieee Vision rehabilitation with the optic nerve visual prosthesis. Proceedings of the 26th Annual International Conference of the Ieee Engineering in Medicine and Biology Society 2004; Vols 1-7: 4163-4164
    CrossrefPubMedGoogle Scholar
  • 43 Veraart C, Duret F, Brelen M, Oozeer M, Delbeke J. Vision rehabilitation in the case of blindness. Expert Review of Medical Devices 2004; 1: 139-153 10.1586/17434440.1.1.139
    CrossrefPubMedGoogle Scholar
  • 44 Walter P. 2016. A fully intraocular approach for a bi-directional retinal prosthesis. In V. P. Gabel (Ed.), Artificial Vision. pp. 151-161 Springer; Heidelberg, New York:
    Google Scholar
  • 45 Walter P. Future Developments in Retinal Prostheses. Klinische Monatsblatter Fur Augenheilkunde 2016; 233: 1238-1243 DOI: 10.1055/s-0042-115411.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 46 Waschkowski F, Hesse S, Rieck AC, Lohmann T, Brockmann C, Laube T, Roessler G. Development of very large electrode arrays for epiretinal stimulation (VLARS). Biomedical Engineering Online. 2014 13. 1110.1186/1475-925x-13-11
    PubMedGoogle Scholar